Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373139 · ClinicalTrials.gov registry record
Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy
A clinical trial, sponsored by Antonios Likourezos.
- Completed
- Registry status
- 633
- Enrollment target
NCT00373139: Completed study, sponsored by Antonios Likourezos.
NCT00373139 is a clinical trial that has completed, run by Antonios Likourezos. The registered enrollment target is 633 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00373139 has completed, sponsored by Antonios Likourezos.
- COMPLETED
- Registry status
- 633 participants
- Enrollment target
Study Summary
It is common practice in the emergency medicine department to rapidly assess pregnancy status through the use of either urine or serum in pregnancy tests. Using whole blood instead of urine would facilitate a much more rapid emergency department identification of pregnancy status. No study to date has utilized whole blood for rapid detection of pregnancy status. Set in the busy adult emergency room at Maimonides Medical Center, this study will recruit a sample of women of reproductive age (18-55), who fit the inclusion criteria of being healthy and in need of a pregnancy test for own purpose or diagnostic testing/treatment. Blood samples will be taken from the participants and used in the hCG kits and the remaining blood was sent to the chemistry laboratory to perform the reference gold standard. The reference gold standard for a positive test is an hCG level \>25mlU/ml. The research investigators and lab will be blinded to each other's results. Kappa statistics will be done for the measurement agreement between urine pregnancy results and whole blood pregnancy results, and whole blood results with laboratory results.
Primary Outcome
Blood will be assessed in a pregnancy kit to assess the sensitivity and specificity of detecting whether or not the patient is pregnant. The laboratory results will be the gold standard.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 633 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-08 |
What the finished NCT00373139 record still lists
NCT00373139 is an observational study that tracks outcomes without assigning an intervention. The registered 633 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00373139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00373139 about?
NCT00373139 is a clinical study titled "Accuracy of Whole-Blood Testing for Rapid Detection of Pregnancy". It is common practice in the emergency medicine department to rapidly assess pregnancy status through the use of either urine or serum in pregnancy tests. Using whole blood instead of urine would facilitate a much more rapid emergency department identification of pregnancy status. No study to date h...
What is the current status of trial NCT00373139?
This trial is currently completed. The enrollment target is 633 participants. The study started on 2006-07. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00373139?
This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia